These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7215535)

  • 1. [Extraneous particle contamination in injectable solutions. Proposed Italian standard].
    Caramella C; Montanari L; Pavanetto F; Ponci R
    Farmaco Prat; 1981 Mar; 36(3):148-61. PubMed ID: 7215535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Foreign particle contamination in high volume injectable solutions and in powders for injectable solutions. Proposals for an Italian standard].
    Montanari L; Pavanetto F; Ponci R
    Farmaco Prat; 1983 Dec; 37(12):397-407. PubMed ID: 6822286
    [No Abstract]   [Full Text] [Related]  

  • 3. [The contamination of large volume parenteral solutions by foreign particles. Proposal for updating the Italian regulations].
    Pavanetto F; Montanari L; Conti B; Ponci R
    Farmaco Prat; 1986 Jan; 41(1):3-14. PubMed ID: 3956714
    [No Abstract]   [Full Text] [Related]  

  • 4. Industry perspective on the medical risk of visible particles in injectable drug products.
    Bukofzer S; Ayres J; Chavez A; Devera M; Miller J; Ross D; Shabushnig J; Vargo S; Watson H; Watson R
    PDA J Pharm Sci Technol; 2015; 69(1):123-39. PubMed ID: 25691720
    [No Abstract]   [Full Text] [Related]  

  • 5. [Microbiological requirements for non-compulsory sterile drugs].
    Aureli P; Pasolini B
    Boll Chim Farm; 1985 Jun; 124(6):229-43. PubMed ID: 4063090
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbial content in non-sterile pharmaceuticals. VI. Oral liquid preparations.
    Lühdorf H; Tybring L
    Dan Tidsskr Farm; 1969; 43(10):229-37. PubMed ID: 4906148
    [No Abstract]   [Full Text] [Related]  

  • 7. Standards for particulate matter in all parenteral drug products.
    Jeffrey LP; Pinkus TF
    Am J Hosp Pharm; 1976 Sep; 33(9):879-80. PubMed ID: 984053
    [No Abstract]   [Full Text] [Related]  

  • 8. [Microbiological investigation of officinal galenical preparations].
    Pirisino G; Piu L; Ginanneschi R
    Boll Chim Farm; 1985 Oct; 124(10):432-8. PubMed ID: 4084398
    [No Abstract]   [Full Text] [Related]  

  • 9. [Validation of demineralized water plants through total microbial count and definition of a microbiological standard].
    Anastasio P; Burinato C; Carazzone M; Ferioli S; Genova R; Malesani L; Molinari ML; Veronese M
    Boll Chim Farm; 1985 Jun; 124(6):259-70. PubMed ID: 4063093
    [No Abstract]   [Full Text] [Related]  

  • 10. [Validation of sterile pharmaceutical production. Considerations and experiences].
    Pongiluppi S
    Boll Chim Farm; 1985 Jul; 124(7):293-305. PubMed ID: 4074520
    [No Abstract]   [Full Text] [Related]  

  • 11. [The problem of pesticide and heavy metal residues in plant-derived drugs used in the pharmaceutical industry].
    Lorusso S; Camoni I; Chiacchierini E
    Nuovi Ann Ig Microbiol; 1985; 36(3):169-80. PubMed ID: 3842759
    [No Abstract]   [Full Text] [Related]  

  • 12. Particulate matter standards for small-volume injections.
    Belson JJ
    Am J Hosp Pharm; 1986 Jun; 43(6):1527-8. PubMed ID: 3728492
    [No Abstract]   [Full Text] [Related]  

  • 13. Particulate inspection of parenteral products: from biophysics to automation.
    Knapp JZ; Kushner HK
    J Parenter Sci Technol; 1982; 36(3):121-7. PubMed ID: 7097455
    [No Abstract]   [Full Text] [Related]  

  • 14. [Control for the absence of mechanical particles in injection solutions].
    Beskrovnyi RP
    Farmatsiia; 1971; 20(2):59-61. PubMed ID: 5562916
    [No Abstract]   [Full Text] [Related]  

  • 15. USP perspectives on particle contamination of injectable products.
    Gallelli JF; Groves MJ
    J Parenter Sci Technol; 1993; 47(6):289-92. PubMed ID: 8120733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method for determination and element analysis of particulate contamination in injectable solutions.
    Winding O; Holma B
    Am J Hosp Pharm; 1976 Nov; 33(11):1154-9. PubMed ID: 998621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specification of limits for particulate contamination in pharmaceutical dosage forms.
    Hailey DM; Lea AR; Kendall CE
    J Pharm Pharmacol; 1982 Oct; 34(10):615-20. PubMed ID: 6128382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Control of foreign particle contamination of injectable solutions].
    Van Ooteghem M; Moës A
    J Pharm Belg; 1972; 27(4):493-504. PubMed ID: 4681079
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of low-level microbial contamination of drug preparations.
    Hess H; Knüsel F; Mullen K
    Pharm Acta Helv; 1969 Mar; 44(3):174-91. PubMed ID: 5790044
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contamination by extraneous particles of injectable solutions of plasma substitutes and iodinated radio-opaque compounds].
    Montanari L; Pavanetto F; Signoretti Ciranni E
    Farmaco Prat; 1983 Jun; 38(6):250-8. PubMed ID: 6884499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.